NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C
( SLLMWITQC )
SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays Antigen Peptide NY-ESO-1 157-165 (9C) (HLA-A*02:01) SLLMWITQC for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
| Sequence: | SLLMWITQC | |
| Gene: | CTAG1A | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Autoimmunogenic cancer/testis antigen NY-ESO-1 | |
| Species: | Human | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Product number:
EP11374_1